Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
<6
EC/CAS
215-138-9/1305-78-8
Name of the chemical
Calcium oxide
Concentration
<0.6
EC/CAS
215-171-9/1309-48-4
Name of the chemical
magnesium oxide
Concentration
<0.5
EC/CAS
215-168-2
Name of the chemical
Iron Oxide Red
Concentration
<5
General Information
Version
1.0
Revision date
2024-10-24
Product name
Aluminum Oxide Powder
supplier name
Buehler
Emergency telephone
+1 760 476 3962, +1 760 476, +1 760 476 3960, +1 760 476 3961
Icons in SDS
Company Information
company name
ITW Test & Measurement GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
custserv@buehler.com, lab.eu@buehler.com
GHS Information
Signal word
(GB CLP
Hazard Codes
Hazard statements (CLP)
H351
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture Classification according to GB CLP (SI 2019:720 as amended) Carcinogenicity, Category 2 H351 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
Suspected of causing cancer
2.2 Label elements
Labelling according to GB CLP (SI 2019:720 as amended)
Hazard pictograms
(GB CLP) GHS08
Signal word
(GB CLP) Warning
Contains
Titanium dioxide
Hazard statements
(GB CLP) H351 - Suspected of causing cancer.
Precautionary statements
(GB CLP) P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing, eye protection, face protection and hearing protection. P308+P313 - IF exposed or concerned: Get medical advice or attention. P405 - Store locked up. P501 - Dispose of contents and container to a hazardous or special waste collection point, in accordance with local, regional, national and international regulations.
2.3 Other hazards
Component Substance(s) not meeting the PBT criteria of UK Titanium dioxide (13463-67-7), Iron oxide (Fe2O3) (1309-37-1), Calcium oxide (1305-78- REACH regulation, in accordance with Annex XIII 8), Magnesium oxide (MgO) (1309-48-4) Substance(s) not meeting the vPvB criteria of UK Titanium dioxide (13463-67-7), Iron oxide (Fe2O3) (1309-37-1), Calcium oxide (1305-78- REACH regulation, in accordance with Annex XIII 8), Magnesium oxide (MgO) (1309-48-4) Component Substance(s) not included in the list established in Titanium dioxide(13463-67-7), Iron oxide (Fe2O3)(1309-37-1), Calcium oxide(1305-78-8), accordance with Article 59(1) of UK REACH for Magnesium oxide (MgO)(1309-48-4) having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in GB BPR and GB PPP
2.1 Classification of the substance or mixture
Classification according to GB CLP (SI 2019:720 as amended) Carcinogenicity, Category 2 H351 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Suspected of causing cancer.
